BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14588080)

  • 1. Management of chronic hepatitis B in an HIV-positive patient with 3TC-resistant hepatitis B virus.
    Ristig M; Drechsler H; Crippin J; Lisker-Melman M; Tebas P
    AIDS Patient Care STDS; 2003 Sep; 17(9):439-42. PubMed ID: 14588080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed.
    Ristig MB; Crippin J; Aberg JA; Powderly WG; Lisker-Melman M; Kessels L; Tebas P
    J Infect Dis; 2002 Dec; 186(12):1844-7. PubMed ID: 12447773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.
    Wiegand J; Tischendorf JJ; Nashan B; Klempnauer J; Flemming P; Niemann P; Rohde P; Manns MP; Trautwein C; Tillmann HL
    Z Gastroenterol; 2004 Jan; 42(1):15-8. PubMed ID: 14997399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV and hepatitis B virus: options for managing coinfection.
    Dieterich DT
    Top HIV Med; 2003; 11(1):16-9. PubMed ID: 12717046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis B in patients with HIV infection].
    Barreiro P; Martín-Carbonero L; García-Samaniego J
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():71-9. PubMed ID: 19100234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Core promoter mutant HBV non-responding to adefovir after viral breakthrough on lamivudine: rapid virologic response to tenofovir plus lamivudine in a cirrhotic patient.
    Katsounas A; Jochum C; Canbay A; Schlaak J; Gerlich WH; Gerken G
    Eur J Med Res; 2008 Oct; 13(10):472-5. PubMed ID: 19008175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenofovir-based combination therapy for HIV/HBV co-infection: factors associated with a partial HBV virological response in patients with undetectable HIV viraemia.
    Childs K; Joshi D; Byrne R; Bruce M; Carey I; Agarwal K; Taylor C
    AIDS; 2013 Jun; 27(9):1443-8. PubMed ID: 23435302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future.
    Núñez M; Puoti M; Camino N; Soriano V
    Clin Infect Dis; 2003 Dec; 37(12):1678-85. PubMed ID: 14689351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar evolution of hepatitis B virus quasispecies in patients with incomplete adefovir response receiving tenofovir/emtricitabine combination or tenofovir monotherapy.
    Lavocat F; Dény P; Pichoud C; Al Hawajri N; Kitrinos K; Borroto-Esoda K; Zoulim F
    J Hepatol; 2013 Oct; 59(4):684-95. PubMed ID: 23742912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis.
    Choe WH; Kwon SY; Kim BK; Ko SY; Yeon JE; Byun KS; Kim GH; Lee CH
    Liver Int; 2008 Jul; 28(6):814-20. PubMed ID: 18312291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern.
    Inoue J; Ueno Y; Wakui Y; Niitsuma H; Fukushima K; Yamagiwa Y; Shiina M; Kondo Y; Kakazu E; Tamai K; Obara N; Iwasaki T; Shimosegawa T
    J Viral Hepat; 2011 Mar; 18(3):206-15. PubMed ID: 20367795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B.
    Fung S; Kwan P; Fabri M; Horban A; Pelemis M; Hann HW; Gurel S; Caruntu FA; Flaherty JF; Massetto B; Dinh P; Corsa A; Subramanian GM; McHutchison JG; Husa P; Gane E
    Gastroenterology; 2014 Apr; 146(4):980-8. PubMed ID: 24368224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir.
    Mikulska M; Taramasso L; Giacobbe DR; Caligiuri P; Bruzzone B; Di Biagio A; Viscoli C
    J Med Virol; 2012 Sep; 84(9):1340-3. PubMed ID: 22825811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No resistance to tenofovir disoproxil fumarate through 96 weeks of treatment in patients with lamivudine-resistant chronic hepatitis B.
    Corsa AC; Liu Y; Flaherty JF; Mitchell B; Fung SK; Gane E; Miller MD; Kitrinos KM
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2106-12.e1. PubMed ID: 24929235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of chronic hepatitis B in the HIV-infected patient.
    Thio CL
    AIDS Read; 2004 Mar; 14(3):122-9, 133, 136-7. PubMed ID: 15068000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of chronic hepatitis B].
    von Weizsäcker F
    Praxis (Bern 1994); 2005 Apr; 94(16):649-52. PubMed ID: 15900829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection.
    Schmutz G; Nelson M; Lutz T; Sheldon J; Bruno R; von Boemmel F; Hoffmann C; Rockstroh J; Stoehr A; Wolf E; Soriano V; Berger F; Berg T; Carlebach A; Schwarze-Zander C; Schürmann D; Jaeger H; Mauss S
    AIDS; 2006 Oct; 20(15):1951-4. PubMed ID: 16988516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants.
    Liu CJ; Kao JH; Chen PJ; Chen TC; Lin FY; Lai MY; Chen DS
    J Viral Hepat; 2006 Jun; 13(6):387-95. PubMed ID: 16842441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals.
    Nelson M; Portsmouth S; Stebbing J; Atkins M; Barr A; Matthews G; Pillay D; Fisher M; Bower M; Gazzard B
    AIDS; 2003 Jan; 17(1):F7-10. PubMed ID: 12478090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine.
    Núñez M; Pérez-Olmeda M; Díaz B; Ríos P; González-Lahoz J; Soriano V
    AIDS; 2002 Nov; 16(17):2352-4. PubMed ID: 12441815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.